Prof. Dr. Dirk Reinhardt
Prof. Dr. Dirk Reinhardt
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| International Phase I Trial of Dinutuximab Beta With VDC/IE in GD2-Positive Ewing Sarkoma | High-risk GD2-Positive Ewing Sarcoma | Not yet recruiting | Phase 1 | 2025-02-21 | NCT06839703 |